Novel combination treatment of CDK 4/6 inhibitors with PARP inhibitors in triple negative breast cancer cells
Gamze Güney Eskiler, Zeynep Özman, Ayten Haciefendi, Demet Cansaran‐Duman
Topics & Concepts
Cancer researchTriple-negative breast cancerPropidium iodideBreast cancerPARP inhibitorCyclin-dependent kinaseCell cyclePoly ADP ribose polymeraseCyclin-dependent kinase 6MedicinePalbociclibApoptosisCancerBiologyInternal medicineProgrammed cell deathPolymeraseMetastatic breast cancerBiochemistryEnzymeAdvanced Breast Cancer TherapiesPARP inhibition in cancer therapyLung Cancer Research Studies